| Literature DB >> 14641915 |
Hsu-Min Tseng1, Jui-fen Rachel Lu, Barbara Gandek.
Abstract
BACKGROUND: The feasibility of using the SF-36 in non-Western cultures is important for researchers seeking to understand cultural influences upon health status perceptions. This paper reports on the performance of the Taiwan version of the SF-36, including the implications of cultural influences.Entities:
Mesh:
Year: 2003 PMID: 14641915 PMCID: PMC385291 DOI: 10.1186/1477-7525-1-72
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Descriptive Statistics for SF-36 Scales
| Mean | SD | Floor (%) | Ceiling (%) | |
| PF – Physical Functioning | 92.60 | 11.47 | 0.0% | 45.3% |
| RP – Role–Physical | 83.56 | 28.88 | 5.9% | 67.9% |
| BP – Bodily Pain | 82.38 | 16.75 | 0.2% | 31.1% |
| GH – General Health | 67.49 | 18.21 | 0.1% | 2.3% |
| VT – Vitality | 65.32 | 15.15 | 0.0% | 0.9% |
| SF – Social Functioning | 79.35 | 16.00 | 0.1% | 19.5% |
| RE – Role–Emotional | 71.32 | 36.98 | 14.1% | 55.4% |
| MH – Mental Health | 68.43 | 14.67 | 0.0% | 1.6% |
Item Descriptive Statistics and Pearson Item-Scale Correlations Corrected for Overlap
| Scale (Choice Range) | Item | Missing | Mean | SD | PF | RP | BP | GH | VT | SF | RE | MH |
| Physical Functioning (1–3) | PF1 | 1.1% | 2.44 | 0.62 | 0.40 | 0.31 | 0.34 | 0.22 | 0.2 | 0.14 | 0.13 | |
| PF2 | 1.1% | 2.87 | 0.38 | 0.33 | 0.29 | 0.25 | 0.17 | 0.18 | 0.05 | 0.11 | ||
| PF3 | 1.1% | 2.91 | 0.32 | 0.29 | 0.28 | 0.18 | 0.11 | 0.14 | 0.07 | 0.06 | ||
| PF4 | 1.0% | 2.75 | 0.48 | 0.32 | 0.28 | 0.23 | 0.17 | 0.15 | 0.11 | 0.12 | ||
| PF5 | 1.2% | 2.96 | 0.22 | 0.25 | 0.25 | 0.18 | 0.16 | 0.18 | 0.13 | 0.10 | ||
| PF6 | 1.0% | 2.88 | 0.36 | 0.29 | 0.32 | 0.22 | 0.15 | 0.16 | 0.11 | 0.11 | ||
| PF7 | 0.8% | 2.85 | 0.39 | 0.33 | 0.2 | 0.23 | 0.23 | 0.21 | 0.19 | 0.18 | ||
| PF8 | 0.8% | 2.92 | 0.30 | 0.36 | 0.22 | 0.17 | 0.17 | 0.22 | 0.17 | 0.10 | ||
| PF9 | 0.9% | 2.98 | 0.17 | 0.19 | 0.16 | 0.12 | 0.07 | 0.10 | 0.09 | 0.05 | ||
| PF10 | 0.8% | 2.98 | 0.16 | 0.18 | 0.12 | 0.12 | 0.10 | 0.13 | 0.13 | 0.10 | ||
| Role Physical (1–2) | RP1 | 0.9% | 1.83 | 0.37 | 0.33 | 0.29 | 0.28 | 0.17 | 0.29 | 0.26 | 0.08 | |
| RP2 | 1.0% | 1.80 | 0.40 | 0.31 | 0.27 | 0.33 | 0.21 | 0.29 | 0.35 | 0.14 | ||
| RP3 | 1.0% | 1.84 | 0.37 | 0.43 | 0.35 | 0.32 | 0.18 | 0.28 | 0.22 | 0.12 | ||
| RP4 | 1.0% | 1.87 | 0.34 | 0.42 | 0.32 | 0.31 | 0.26 | 0.30 | 0.23 | 0.19 | ||
| Bodily Pain (1–6) | BP1 | 0.2% | 4.88 | 1.02 | 0.33 | 0.31 | 0.40 | 0.28 | 0.29 | 0.17 | 0.25 | |
| BP2 | 1.1% | 4.53 | 0.65 | 0.37 | 0.41 | 0.37 | 0.28 | 0.42 | 0.26 | 0.23 | ||
| General Health (1–5) | GH1 | 0.0% | 3.05 | 0.97 | 0.28 | 0.33 | 0.33 | 0.41 | 0.24 | 0.17 | 0.30 | |
| GH2 | 2.7% | 3.85 | 1.07 | 0.19 | 0.30 | 0.34 | 0.34 | 0.26 | 0.21 | 0.27 | ||
| GH3 | 2.5% | 3.94 | 0.96 | 0.20 | 0.23 | 0.25 | 0.37 | 0.21 | 0.16 | 0.32 | ||
| GH4 | 2.6% | 3.86 | 1.08 | 0.29 | 0.28 | 0.28 | 0.32 | 0.27 | 0.16 | 0.28 | ||
| GH5 | 2.5% | 3.80 | 0.92 | 0.27 | 0.31 | 0.37 | 0.46 | 0.30 | 0.21 | 0.40 | ||
| Vitality (1–6) | VT1 | 1.2% | 4.34 | 1.09 | 0.18 | 0.23 | 0.21 | 0.42 | 0.34 | 0.26 | 0.52 | |
| VT2 | 1.2% | 4.14 | 1.09 | 0.20 | 0.15 | 0.23 | 0.44 | 0.33 | 0.25 | 0.59 | ||
| VT3 | 1.2% | 4.47 | 0.90 | 0.23 | 0.24 | 0.24 | 0.33 | 0.32 | 0.26 | 0.44 | ||
| VT4 | 1.0% | 4.11 | 0.90 | 0.16 | 0.17 | 0.27 | 0.35 | 0.35 | 0.23 | 0.53 | ||
| Social Functioning (1–5) | SF1 | 0.1% | 4.44 | 0.69 | 0.18 | 0.31 | 0.33 | 0.28 | 0.29 | 0.39 | 0.41 | |
| SF2 | 2.5% | 3.91 | 0.84 | 0.25 | 0.32 | 0.32 | 0.31 | 0.43 | 0.30 | 0.42 | ||
| Role Emotional (1–2) | RE1 | 0.3% | 1.74 | 0.44 | 0.17 | 0.31 | 0.18 | 0.20 | 0.27 | 0.37 | 0.32 | |
| RE2 | 0.2% | 1.71 | 0.45 | 0.17 | 0.32 | 0.19 | 0.21 | 0.26 | 0.33 | 0.29 | ||
| RE3 | 0.3% | 1.69 | 0.46 | 0.11 | 0.22 | 0.19 | 0.20 | 0.29 | 0.30 | 0.32 | ||
| Mental Health (1–6) | MH1 | 1.2% | 4.07 | 1.10 | 0.11 | 0.12 | 0.21 | 0.28 | 0.34 | 0.26 | 0.22 | |
| MH2 | 1.5% | 4.69 | 0.92 | 0.15 | 0.12 | 0.17 | 0.29 | 0.52 | 0.38 | 0.29 | ||
| MH3 | 1.2% | 4.31 | 1.02 | 0.14 | 0.12 | 0.24 | 0.34 | 0.54 | 0.37 | 0.32 | ||
| MH4 | 1.2% | 4.53 | 0.91 | 0.11 | 0.12 | 0.19 | 0.31 | 0.54 | 0.41 | 0.28 | ||
| MH5 | 1.0% | 4.50 | 1.07 | 0.11 | 0.13 | 0.17 | 0.34 | 0.60 | 0.37 | 0.27 |
a denotes correlation between an item and its hypothesized scale.
Reliabilty Statistics and Correlations between SF-36 Scales
| Scale | PF | RP | BP | GH | VT | SF | RE | MH |
| PF – Physical Functioning | (0.83) | |||||||
| RP – Role–Physical | 0.47 | (0.79) | ||||||
| BP – Bodily Pain | 0.39 | 0.39 | (0.70) | |||||
| GH – General Health | 0.34 | 0.40 | 0.43 | (0.78) | ||||
| VT – Vitality | 0.25 | 0.26 | 0.31 | 0.51 | (0.75) | |||
| SF – Social Functioning | 0.26 | 0.37 | 0.38 | 0.35 | 0.44 | ( | ||
| RE – Role–Emotional | 0.18 | 0.34 | 0.23 | 0.25 | 0.33 | 0.41 | (0.75) | |
| MH – Mental Health | 0.17 | 0.17 | 0.27 | 0.43 | 0.69 | 0.49 | 0.38 | (0.78) |
Note. Scale reliability was represented on the diagonal. Internal consistency reliability lower than recommended level of 0.70 were shown with underlined entries.
Factor Loadings of the 8 SF-36 scales using rotated principal components in Taiwan, Japan, Hong Kong and the US
| Rotated Principal Components a | ||||||||||
| Physical | Mental | |||||||||
| Scale | Expected | Taiwan | Japan | HK | US | Expected | Taiwan | Japan | HK | US |
| PF | ● | 0.80 | 0.75 | 0.78 | 0.85 | ○ | 0.09 | 0.17 | -0.08 | 0.12 |
| RP | ● | 0.80 | 0.86 | 0.63 | 0.81 | ○ | 0.19 | 0.19 | 0.34 | 0.27 |
| BP | ● | 0.64 | 0.51 | 0.61 | 0.76 | ○ | 0.28 | 0.52 | 0.23 | 0.28 |
| GH | ◐ | 0.46 | 0.37 | 0.70 | 0.69 | ◐ | 0.56 | 0.66 | 0.10 | 0.37 |
| VT | ◐ | 0.16 | 0.21 | 0.48 | 0.47 | ◐ | 0.84 | 0.88 | 0.51 | 0.64 |
| SF | ◐ | 0.38 | 0.45 | 0.20 | 0.42 | ● | 0.61 | 0.60 | 0.74 | 0.67 |
| RE | ○ | 0.30 | 0.69 | 0.05 | 0.17 | ● | 0.54 | 0.34 | 0.74 | 0.78 |
| MH | ○ | 0.02 | 0.13 | 0.10 | 0.17 | ● | 0.90 | 0.89 | 0.77 | 0.87 |
● Strong association (r ≥ .70) ◐ Moderate to substantial association (.30 < r < .70) ○ Weak association (r ≤ .30) a Correlations between each scale and rotated principal component. Source: Data for US is from Ware, J., Snow, K., Kosinski, M., & Gandek, B. (1993). SF-36 Health Survey: Manual & Interpretation Guide. MA: Boston: Nimrod Press. Data for Japan is from Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B (1998). Psychometric and Clinical Tests of Validity of the Japanese SF-36 Health Survey. J Clin Epidemiol, 51, 1998; 51: 1045–1053 Data for HK is from Lam, C. L., Gandek, B., Ren, X. S., & Chan, M. S. (1998). Tests of scaling assumptions and construct validity of the Chinese (HK) version of the SF-36 Health Survey. J Clin Epidemiol, 51, 1139–1147.
Correlations between the SF-36 Health Survey and the Stress Coping Inventory (N = 569)
| Stress Coping Inventory SF-36 | Resources | Psychological Symptoms | |||
| Self-Esteem | Family Support | Friendship Support | Anxiety | Depression | |
| PF – Physical Functioning | 0.29 | 0.11 | 0.22 | -0.30 | |
| RP – Role–Physical | 0.18 | 0.13 | 0.20 | -0.29 | -0.21 |
| BP – Bodily Pain | 0.15 | 0.14 | 0.17 | -0.28 | -0.26 |
| GH – General Health | 0.23 | 0.29 | |||
| VT – Vitality | 0.26 | ||||
| SF – Social Functioning | 0.20 | 0.27 | |||
| RE – Role–Emotional | 0.18 | 0.08 | 0.15 | ||
| MH – Mental Health | 0.22 | ||||
Note: All correlation coefficients in this table are statistically significant (p < 0.05). Underlined entries represent Moderate to Substantial associations (.30 < r < .70)
Figure 1Comparison of SF-36 Scale Profiles between the Student and Elderly Sample.